Wendall Wierenga - Sep 1, 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
Stock symbol
CYTK
Transactions as of
Sep 1, 2022
Transactions value $
-$191,678
Form type
4
Date filed
9/1/2022, 06:19 PM
Previous filing
Jul 12, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $28.2K +4.17K +34.23% $6.78* 16.3K Sep 1, 2022 Direct F1
transaction CYTK Common Stock Sale -$220K -4.17K -25.5% $52.79 12.2K Sep 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -4.17K -100% $0.00* 0 Sep 1, 2022 Common Stock 4.17K $6.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.